A rigorous study of TN lifesciences is afoot and advocates are clearly positioning to push for public and private support.
The word is just getting out about new entrant in Tennessee biopharm ecosystem.
Healthcare IT, solutions and consulting provider has apparently passed a revenue milestone.
Former BioMimetic Therapeutics executives at center of new initiatives.
[updated] A baker's dozen oughta-reads on startups and capital from around the state.
VTC A fresh assay has led to new focus and renewed vision for regional service and leadership.
Cautious handling by proponents seems likely to advance state programs, stepwise.
Developers studying HudsonAlpha and other innovation centers.
[Updated] Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
[updated] Williamson County aims to breed its Tech sector, leverages NEC resources
President James Stover says company has good talks with potential strategic partners
[EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders
Scholar and entrepreneur will co-found molecular diagnostics startup in Nashville
Another 'complaining' serial entrepreneur is having trouble retiring, as one venture happily leads to another
Lynch cites workforce challenges and the need for more collaboration throughout the region as essential to lift Nashville from lower tier of life-science centers
At left, Dr. Harry Jacobson
At left, Ken Woody
[updated] Though their faith in the future may vary, retained executive-search professionals are investing energy in Bio and related fields.
The yet-to-be-operational TNInvestco capital-formation program seems to have kindled fresh interest in key sectors
With former VC hired to lead program, grant for entrepreneurship helps flesh-out tech-development ecosystem
TTDC lands prominent healthcare CEO, scientist and policy influential to help navigate the shores of business, academe and government
At deal-making summit, investment bankers and others say focus on regulatory pressure for cost-reductions, rather than on next President
While critics sound off and Biotech targets General Assembly, an economy-shaping executive keeps pushing education and innovations
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: